Literature DB >> 23548288

Metritis in dairy cows: risk factors and reproductive performance.

M J Giuliodori1, R P Magnasco, D Becu-Villalobos, I M Lacau-Mengido, C A Risco, R L de la Sota.   

Abstract

The objectives of this study were to assess the risk factors for metritis, its effects on milk yield and on reproductive performance, and the efficacy of ceftiofur therapy in Holstein dairy cows. Cows (n=303) from a commercial dairy herd in Argentina were studied. Cows were scored for body condition, and blood samples were collected on d -14, 7, 21, 31, 41, and 50 relative to parturition. Cows having a watery, purulent, or brown, and fetid vaginal discharge (VD) and rectal temperature ≤ 39.2°C were diagnosed as having clinical metritis, and those having a similar VD and rectal temperature >39.2°C were diagnosed as having puerperal metritis. Both clinical and puerperal metritis cows were randomly assigned to control (no treatment) or ceftiofur group (2.2mg/kg×3 consecutive days). Cure was declared if clear VD was observed at 21 d in milk (DIM). Blood samples were analyzed for nonesterified fatty acids, β-hydroxybutyrate, and blood urea nitrogen using commercial kits, and for insulin-like growth factor-1, insulin, and leptin by RIA. Data were analyzed with PROC MIXED, GENMOD, PHREG, and LIFETEST from SAS (SAS Institute Inc., Cary, NC). The risk for metritis increased with dystocia, retained fetal membranes, and dead calf [AOR (adjusted odds ratio)=2.58, 95% CI: 1.189-5.559], and as prepartum nonesterified fatty acids levels increased (AOR=1.001, 95% CI: 0.999-1.002). Conversely, risk decreased as prepartum insulin-like growth factor-1 increased (AOR=0.65, 95% CI: 0.349-1.219). Cows having either clinical or puerperal metritis produced less milk by 90 DIM than did healthy cows (2,236 ± 172 vs. 2,367 ± 77 vs. 2,647 ± 82 kg, respectively). Cows with puerperal metritis had lower risk for pregnancy by 100 DIM (AOR=0.189, 95% CI: 0.070-0.479) and a lower hazard rate for pregnancy by 150 DIM (hazard rate: 0.753, 95% CI: 0.621-0.911), and took longer to get pregnant (129 vs. 111 vs. 109 d, for puerperal metritis, clinical metritis, and healthy cows, respectively). Ceftiofur treatment was not associated with cure rate or milk yield but was related to increased risk for pregnancy at timed artificial insemination (AOR=2.688, 95% CI: 0.687-10.832), and for lower risk of reproductive cull (AOR=0.121, 95% CI: 0.014-1.066). In conclusion, abnormal calving and negative energy balance are associated with increased risk for metritis. Metritis, especially puerperal metritis, correlates with reduced milk production and poor reproductive performance. Finally, the likelihood for having a normal VD (indicative of cure) increased 2.6% for every day of increase in postpartum time and was 2 times higher for cows with clinical metritis than for those with puerperal metritis.
Copyright © 2013 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548288     DOI: 10.3168/jds.2012-5922

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  21 in total

1.  Association between 4-day vaginal temperature assessment during the dry period and performance in the subsequent lactation of dairy cows during the warm season.

Authors:  A L A Scanavez; B Fragomeni; L Rocha; B E Voelz; L E Hulbert; L G D Mendonça
Journal:  J Anim Sci       Date:  2017-12       Impact factor: 3.159

2.  Interrelationship between diseases and calving season and their impact on reproductive parameters and milk production of tropical dairy cows.

Authors:  Joaquín M Castro-Montoya; F L González; M V Mendoza; K Harper; E E Corea
Journal:  Trop Anim Health Prod       Date:  2022-04-05       Impact factor: 1.559

3.  Retrospective Evaluation of Method of Treatment, Laboratory Findings, and Concurrent Diseases in Dairy Cattle Diagnosed with Left Displacement of the Abomasum during Time of Hospitalization.

Authors:  Theresa Tschoner; Yury Zablotski; Melanie Feist
Journal:  Animals (Basel)       Date:  2022-06-27       Impact factor: 3.231

4.  Prevalence of early postpartum health disorders in Holstein cows and associations with production, reproduction, and survival outcomes on Alberta dairy farms.

Authors:  Kira Macmillan; Mohanathas Gobikrushanth; Amir Behrouzi; Brent Hoff; Marcos G Colazo
Journal:  Can Vet J       Date:  2021-03       Impact factor: 1.008

5.  Characterisation of peripheral blood mononuclear cell populations in periparturient dairy cows that develop metritis.

Authors:  John J Bromfield; Meghan M Watt; Sossi M Iacovides
Journal:  Vet Immunol Immunopathol       Date:  2018-04-30       Impact factor: 2.046

6.  Association between Prepartum Feeding Behavior and Periparturient Health Disorders in Dairy Cows.

Authors:  Karen M Luchterhand; Paula R B Silva; Ricardo C Chebel; Marcia I Endres
Journal:  Front Vet Sci       Date:  2016-08-22

7.  Uterine Microbiota and Immune Parameters Associated with Fever in Dairy Cows with Metritis.

Authors:  Soo Jin Jeon; Federico Cunha; Xiaojie Ma; Natalia Martinez; Achilles Vieira-Neto; Rodolfo Daetz; Rodrigo C Bicalho; Svetlana Lima; Jose E P Santos; K Casey Jeong; Klibs N Galvão
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

8.  A longitudinal cohort study of acute puerperal metritis cases in Swedish dairy cows.

Authors:  Anna Ordell; Helle Ericsson Unnerstad; Ann Nyman; Hans Gustafsson; Renée Båge
Journal:  Acta Vet Scand       Date:  2016-11-10       Impact factor: 1.695

9.  Potential Benefits to Dairy Cow Welfare of Using a Ceftiofur-Ketoprofen Combination Drug for the Treatment of Inflammatory Disease Associated with Pyrexia: A Field Clinical Trial on Acute Puerperal Metritis.

Authors:  Isabella Lora; Mattia Massignani; Annalisa Stefani; Flaviana Gottardo
Journal:  Animals (Basel)       Date:  2021-05-28       Impact factor: 2.752

10.  Glucose Availability and AMP-Activated Protein Kinase Link Energy Metabolism and Innate Immunity in the Bovine Endometrium.

Authors:  Matthew L Turner; James G Cronin; Pablo G Noleto; I Martin Sheldon
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.